Verrica Pharmaceuticals
Price & Volume
Stats
See more52W Range | $3.81-$17.38 |
Market Cap | $41.7M |
Shares Short | 169,855 |
Financials
See moreRevenue (12 Mos) | $14.7M |
Revenue Growth (YoY) | 145.4% |
Gross Profit (12 Mos) | $5M |
Diluted EPS | -$7.74 |
News
See moreYahoo Finance • 3 days ago
Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Yahoo Finance • 21 days ago
Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH® (TO-208) in Japan for the Treatment of Molluscum Contagiosum
Yahoo Finance • 2 months ago
Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results
About
CEO | Dr. Jayson M. Rieger M.B.A., Ph.D. |
Address | 44 West Gay Street, West Chester, PA, United States, 19380 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 71 |
